Skip to Content
Merck
CN
  • Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals.

Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals.

Journal of lipid research (2007-01-16)
Sandrine Bacot, Nathalie Bernoud-Hubac, Bernard Chantegrel, Christian Deshayes, Alain Doutheau, Gabriel Ponsin, Michel Lagarde, Michel Guichardant
ABSTRACT

Hydroxy-alkenals, such as 4-hydroxy-2(E)-nonenal (4-HNE; from n-6 fatty acids), are degradation products of fatty acid hydroperoxides, including those generated by free radical attack of membrane polyunsaturated fatty acyl moieties. The cytotoxic effects of hydroxy-alkenals are well known and are mainly attributable to their interaction with different molecules to form covalent adducts. Indeed, ethanolamine phospholipids (PEs) can be covalently modified in a cellular system by hydroxy-alkenals, such as 4-HNE, 4-hydroxy-2(E)-hexenal (4-HHE; from n-3 fatty acids), and 4-hydroxy-dodecadienal (4-HDDE; from the 12-lipoxygenase product of arachidonic acid), to form mainly Michael adducts. In this study, we describe the formation of PE Michael adducts in human blood platelets in response to oxidative stress and in retinas of streptozotocin-induced diabetic rats. We have successfully characterized and evaluated, for the first time, PEs coupled with 4-HHE, 4-HNE, and 4-HDDE by gas chromatography-mass spectrometry measurement of their ethanolamine moieties. We also report that aggregation of isolated human blood platelets enriched with PE-4-hydroxy-alkenal Michael adducts was altered. These data suggest that these adducts could be used as specific markers of membrane disorders occurring in pathophysiological states with associated oxidative stress and might affect cell function.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1-(Trifluoroacetyl)imidazole, 98%